LUCIGEN CORPORATION

Lucigen Corporation specializes in the production and handling of biological materials and media, alongside advanced research in nanotechnology and organic chemical synthesis. Their core capabilities center on the manufacturing and logistical support of sensitive biological substances for research and defense applications, with demonstrated expertise in whole-genome and metagenomics services, including sample preparation, sequencing workflows, and high-complexity molecular media formulation. The company applies precise chemical synthesis techniques to produce specialized organic compounds essential for biological research, and integrates nanoscale technologies to enhance molecular analysis and delivery systems. Their technical differentiators lie in end-to-end support for genomic workflows, from reagent manufacturing to lab-scale processing, ensuring reproducibility and compliance in high-containment environments. Lucigen has established a consistent relationship with the Department of Health and Human Services, primarily supporting biological material supply chains for research and diagnostic infrastructure, and has also delivered specialized genomic services to the Department of Defense, indicating engagement in defense-relevant life sciences applications. Their work for these agencies suggests a focus on mission-critical biological supply chains and advanced molecular diagnostics. The company’s primary industry focus is in biological product manufacturing, organic chemical synthesis, and nanotechnology R&D—domains requiring stringent quality control, sterile processing, and regulatory adherence. This positions Lucigen as a niche provider of specialized reagents and analytical support services for government-funded biomedical and defense research programs. As a small business structured as a 2L entity based in Middleton, Wisconsin, Lucigen operates with a focused, technically driven model. While currently holding no formal government certifications, its geographic presence in a hub of biotech research enables close collaboration with federal laboratories and academic partners, reinforcing its role as a specialized supplier in the federal life sciences ecosystem.